img

Global Oral Rotavirus Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Rotavirus Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Oral Rotavirus Vaccine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Oral Rotavirus Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Oral Rotavirus Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Oral Rotavirus Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Oral Rotavirus Vaccine include GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group and Sinovac Biotech, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Oral Rotavirus Vaccine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Oral Rotavirus Vaccine by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Oral Rotavirus Vaccine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Oral Rotavirus Vaccine market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


GSK
Sanofi-Pasteur
Merck
Biological E. Limited
China National Biotec Group
Sinovac Biotech
By Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
By Application
Hospital
Vaccination Station
Other
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Oral Rotavirus Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Oral Rotavirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Rotavirus Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Oral Rotavirus Vaccine Definition
1.2 Market by Type
1.2.1 Global Oral Rotavirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.3 Market Segment by Application
1.3.1 Global Oral Rotavirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Vaccination Station
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Oral Rotavirus Vaccine Sales
2.1 Global Oral Rotavirus Vaccine Revenue Estimates and Forecasts 2018-2034
2.2 Global Oral Rotavirus Vaccine Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Oral Rotavirus Vaccine Revenue by Region
2.3.1 Global Oral Rotavirus Vaccine Revenue by Region (2018-2024)
2.3.2 Global Oral Rotavirus Vaccine Revenue by Region (2024-2034)
2.4 Global Oral Rotavirus Vaccine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Oral Rotavirus Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Oral Rotavirus Vaccine Sales Quantity by Region
2.6.1 Global Oral Rotavirus Vaccine Sales Quantity by Region (2018-2024)
2.6.2 Global Oral Rotavirus Vaccine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Oral Rotavirus Vaccine Sales Quantity by Manufacturers
3.1.1 Global Oral Rotavirus Vaccine Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Oral Rotavirus Vaccine Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Oral Rotavirus Vaccine Sales in 2022
3.2 Global Oral Rotavirus Vaccine Revenue by Manufacturers
3.2.1 Global Oral Rotavirus Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Oral Rotavirus Vaccine Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Oral Rotavirus Vaccine Revenue in 2022
3.3 Global Oral Rotavirus Vaccine Sales Price by Manufacturers
3.4 Global Key Players of Oral Rotavirus Vaccine, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Oral Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oral Rotavirus Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oral Rotavirus Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Oral Rotavirus Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Oral Rotavirus Vaccine Sales Quantity by Type
4.1.1 Global Oral Rotavirus Vaccine Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Oral Rotavirus Vaccine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Oral Rotavirus Vaccine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Oral Rotavirus Vaccine Revenue by Type
4.2.1 Global Oral Rotavirus Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Oral Rotavirus Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Oral Rotavirus Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Oral Rotavirus Vaccine Price by Type
4.3.1 Global Oral Rotavirus Vaccine Price by Type (2018-2024)
4.3.2 Global Oral Rotavirus Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Oral Rotavirus Vaccine Sales Quantity by Application
5.1.1 Global Oral Rotavirus Vaccine Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Oral Rotavirus Vaccine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Oral Rotavirus Vaccine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Oral Rotavirus Vaccine Revenue by Application
5.2.1 Global Oral Rotavirus Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Oral Rotavirus Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Oral Rotavirus Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Oral Rotavirus Vaccine Price by Application
5.3.1 Global Oral Rotavirus Vaccine Price by Application (2018-2024)
5.3.2 Global Oral Rotavirus Vaccine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Oral Rotavirus Vaccine Sales by Company
6.1.1 North America Oral Rotavirus Vaccine Revenue by Company (2018-2024)
6.1.2 North America Oral Rotavirus Vaccine Sales Quantity by Company (2018-2024)
6.2 North America Oral Rotavirus Vaccine Market Size by Type
6.2.1 North America Oral Rotavirus Vaccine Sales Quantity by Type (2018-2034)
6.2.2 North America Oral Rotavirus Vaccine Revenue by Type (2018-2034)
6.3 North America Oral Rotavirus Vaccine Market Size by Application
6.3.1 North America Oral Rotavirus Vaccine Sales Quantity by Application (2018-2034)
6.3.2 North America Oral Rotavirus Vaccine Revenue by Application (2018-2034)
6.4 North America Oral Rotavirus Vaccine Market Size by Country
6.4.1 North America Oral Rotavirus Vaccine Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Oral Rotavirus Vaccine Revenue by Country (2018-2034)
6.4.3 North America Oral Rotavirus Vaccine Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Oral Rotavirus Vaccine Sales by Company
7.1.1 Europe Oral Rotavirus Vaccine Sales Quantity by Company (2018-2024)
7.1.2 Europe Oral Rotavirus Vaccine Revenue by Company (2018-2024)
7.2 Europe Oral Rotavirus Vaccine Market Size by Type
7.2.1 Europe Oral Rotavirus Vaccine Sales Quantity by Type (2018-2034)
7.2.2 Europe Oral Rotavirus Vaccine Revenue by Type (2018-2034)
7.3 Europe Oral Rotavirus Vaccine Market Size by Application
7.3.1 Europe Oral Rotavirus Vaccine Sales Quantity by Application (2018-2034)
7.3.2 Europe Oral Rotavirus Vaccine Revenue by Application (2018-2034)
7.4 Europe Oral Rotavirus Vaccine Market Size by Country
7.4.1 Europe Oral Rotavirus Vaccine Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Oral Rotavirus Vaccine Revenue by Country (2018-2034)
7.4.3 Europe Oral Rotavirus Vaccine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Oral Rotavirus Vaccine Sales by Company
8.1.1 China Oral Rotavirus Vaccine Sales Quantity by Company (2018-2024)
8.1.2 China Oral Rotavirus Vaccine Revenue by Company (2018-2024)
8.2 China Oral Rotavirus Vaccine Market Size by Type
8.2.1 China Oral Rotavirus Vaccine Sales Quantity by Type (2018-2034)
8.2.2 China Oral Rotavirus Vaccine Revenue by Type (2018-2034)
8.3 China Oral Rotavirus Vaccine Market Size by Application
8.3.1 China Oral Rotavirus Vaccine Sales Quantity by Application (2018-2034)
8.3.2 China Oral Rotavirus Vaccine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Oral Rotavirus Vaccine Sales by Company
9.1.1 APAC Oral Rotavirus Vaccine Sales Quantity by Company (2018-2024)
9.1.2 APAC Oral Rotavirus Vaccine Revenue by Company (2018-2024)
9.2 APAC Oral Rotavirus Vaccine Market Size by Type
9.2.1 APAC Oral Rotavirus Vaccine Sales Quantity by Type (2018-2034)
9.2.2 APAC Oral Rotavirus Vaccine Revenue by Type (2018-2034)
9.3 APAC Oral Rotavirus Vaccine Market Size by Application
9.3.1 APAC Oral Rotavirus Vaccine Sales Quantity by Application (2018-2034)
9.3.2 APAC Oral Rotavirus Vaccine Revenue by Application (2018-2034)
9.4 APAC Oral Rotavirus Vaccine Market Size by Region
9.4.1 APAC Oral Rotavirus Vaccine Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Oral Rotavirus Vaccine Revenue by Region (2018-2034)
9.4.3 APAC Oral Rotavirus Vaccine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales by Company
10.1.1 Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Oral Rotavirus Vaccine Market Size by Type
10.2.1 Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Oral Rotavirus Vaccine Market Size by Application
10.3.1 Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Oral Rotavirus Vaccine Market Size by Country
10.4.1 Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Oral Rotavirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 GSK Oral Rotavirus Vaccine Products and Services
11.1.5 GSK Oral Rotavirus Vaccine SWOT Analysis
11.1.6 GSK Recent Developments
11.2 Sanofi-Pasteur
11.2.1 Sanofi-Pasteur Company Information
11.2.2 Sanofi-Pasteur Overview
11.2.3 Sanofi-Pasteur Oral Rotavirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Sanofi-Pasteur Oral Rotavirus Vaccine Products and Services
11.2.5 Sanofi-Pasteur Oral Rotavirus Vaccine SWOT Analysis
11.2.6 Sanofi-Pasteur Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Oral Rotavirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Merck Oral Rotavirus Vaccine Products and Services
11.3.5 Merck Oral Rotavirus Vaccine SWOT Analysis
11.3.6 Merck Recent Developments
11.4 Biological E. Limited
11.4.1 Biological E. Limited Company Information
11.4.2 Biological E. Limited Overview
11.4.3 Biological E. Limited Oral Rotavirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Biological E. Limited Oral Rotavirus Vaccine Products and Services
11.4.5 Biological E. Limited Oral Rotavirus Vaccine SWOT Analysis
11.4.6 Biological E. Limited Recent Developments
11.5 China National Biotec Group
11.5.1 China National Biotec Group Company Information
11.5.2 China National Biotec Group Overview
11.5.3 China National Biotec Group Oral Rotavirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 China National Biotec Group Oral Rotavirus Vaccine Products and Services
11.5.5 China National Biotec Group Oral Rotavirus Vaccine SWOT Analysis
11.5.6 China National Biotec Group Recent Developments
11.6 Sinovac Biotech
11.6.1 Sinovac Biotech Company Information
11.6.2 Sinovac Biotech Overview
11.6.3 Sinovac Biotech Oral Rotavirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Sinovac Biotech Oral Rotavirus Vaccine Products and Services
11.6.5 Sinovac Biotech Oral Rotavirus Vaccine SWOT Analysis
11.6.6 Sinovac Biotech Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Oral Rotavirus Vaccine Value Chain Analysis
12.2 Oral Rotavirus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Rotavirus Vaccine Production Mode & Process
12.4 Oral Rotavirus Vaccine Sales and Marketing
12.4.1 Oral Rotavirus Vaccine Sales Channels
12.4.2 Oral Rotavirus Vaccine Distributors
12.5 Oral Rotavirus Vaccine Customers
13 Market Dynamics
13.1 Oral Rotavirus Vaccine Industry Trends
13.2 Oral Rotavirus Vaccine Market Drivers
13.3 Oral Rotavirus Vaccine Market Challenges
13.4 Oral Rotavirus Vaccine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Oral Rotavirus Vaccine Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Rotarix
Table 3. Major Manufacturers of RotaTeq
Table 4. Major Manufacturers of Rotavac
Table 5. Major Manufacturers of Rotavin-M1
Table 6. Major Manufacturers of Lanzhou lamb
Table 7. Global Oral Rotavirus Vaccine Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Oral Rotavirus Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Oral Rotavirus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Oral Rotavirus Vaccine Revenue Market Share by Region (2018-2024)
Table 11. Global Oral Rotavirus Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Oral Rotavirus Vaccine Revenue Market Share by Region (2024-2034)
Table 13. Global Oral Rotavirus Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Pcs)
Table 14. Global Oral Rotavirus Vaccine Sales by Region (2018-2024) & (K Pcs)
Table 15. Global Oral Rotavirus Vaccine Sales Market Share by Region (2018-2024)
Table 16. Global Oral Rotavirus Vaccine Sales by Region (2024-2034) & (K Pcs)
Table 17. Global Oral Rotavirus Vaccine Sales Market Share by Region (2024-2034)
Table 18. Global Oral Rotavirus Vaccine Sales Quantity by Manufacturers (2018-2024) & (K Pcs)
Table 19. Global Oral Rotavirus Vaccine Sales Quantity Share by Manufacturers (2018-2024)
Table 20. Global Oral Rotavirus Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Oral Rotavirus Vaccine Revenue Share by Manufacturers (2018-2024)
Table 22. Global Oral Rotavirus Vaccine Price by Manufacturers 2018-2024 (USD/Pcs)
Table 23. Global Key Players of Oral Rotavirus Vaccine, Industry Ranking, 2021 VS 2022
Table 24. Global Oral Rotavirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Oral Rotavirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Rotavirus Vaccine as of 2022)
Table 26. Global Key Manufacturers of Oral Rotavirus Vaccine, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Oral Rotavirus Vaccine, Product Offered and Application
Table 28. Global Key Manufacturers of Oral Rotavirus Vaccine, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Oral Rotavirus Vaccine Sales Quantity by Type (2018-2024) & (K Pcs)
Table 31. Global Oral Rotavirus Vaccine Sales Quantity by Type (2024-2034) & (K Pcs)
Table 32. Global Oral Rotavirus Vaccine Sales Quantity Share by Type (2018-2024)
Table 33. Global Oral Rotavirus Vaccine Sales Quantity Share by Type (2024-2034)
Table 34. Global Oral Rotavirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Oral Rotavirus Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Oral Rotavirus Vaccine Revenue Share by Type (2018-2024)
Table 37. Global Oral Rotavirus Vaccine Revenue Share by Type (2024-2034)
Table 38. Oral Rotavirus Vaccine Price by Type (2018-2024) & (USD/Pcs)
Table 39. Global Oral Rotavirus Vaccine Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 40. Global Oral Rotavirus Vaccine Sales Quantity by Application (2018-2024) & (K Pcs)
Table 41. Global Oral Rotavirus Vaccine Sales Quantity by Application (2024-2034) & (K Pcs)
Table 42. Global Oral Rotavirus Vaccine Sales Quantity Share by Application (2018-2024)
Table 43. Global Oral Rotavirus Vaccine Sales Quantity Share by Application (2024-2034)
Table 44. Global Oral Rotavirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Oral Rotavirus Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Oral Rotavirus Vaccine Revenue Share by Application (2018-2024)
Table 47. Global Oral Rotavirus Vaccine Revenue Share by Application (2024-2034)
Table 48. Oral Rotavirus Vaccine Price by Application (2018-2024) & (USD/Pcs)
Table 49. Global Oral Rotavirus Vaccine Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 50. North America Oral Rotavirus Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 51. North America Oral Rotavirus Vaccine Sales Quantity by Company (2018-2024) & (K Pcs)
Table 52. North America Oral Rotavirus Vaccine Sales Quantity by Type (2018-2024) & (K Pcs)
Table 53. North America Oral Rotavirus Vaccine Sales Quantity by Type (2024-2034) & (K Pcs)
Table 54. North America Oral Rotavirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 55. North America Oral Rotavirus Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Oral Rotavirus Vaccine Sales Quantity by Application (2018-2024) & (K Pcs)
Table 57. North America Oral Rotavirus Vaccine Sales Quantity by Application (2024-2034) & (K Pcs)
Table 58. North America Oral Rotavirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 59. North America Oral Rotavirus Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Oral Rotavirus Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 61. North America Oral Rotavirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 62. North America Oral Rotavirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Oral Rotavirus Vaccine Sales Quantity by Country (2018-2024) & (K Pcs)
Table 64. North America Oral Rotavirus Vaccine Sales Quantity by Country (2024-2034) & (K Pcs)
Table 65. Europe Oral Rotavirus Vaccine Sales Quantity by Company (2018-2024) & (K Pcs)
Table 66. Europe Oral Rotavirus Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 67. Europe Oral Rotavirus Vaccine Sales Quantity by Type (2018-2024) & (K Pcs)
Table 68. Europe Oral Rotavirus Vaccine Sales Quantity by Type (2024-2034) & (K Pcs)
Table 69. Europe Oral Rotavirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 70. Europe Oral Rotavirus Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Oral Rotavirus Vaccine Sales Quantity by Application (2018-2024) & (K Pcs)
Table 72. Europe Oral Rotavirus Vaccine Sales Quantity by Application (2024-2034) & (K Pcs)
Table 73. Europe Oral Rotavirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 74. Europe Oral Rotavirus Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Oral Rotavirus Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 76. Europe Oral Rotavirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 77. Europe Oral Rotavirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Oral Rotavirus Vaccine Sales Quantity by Country (2018-2024) & (K Pcs)
Table 79. Europe Oral Rotavirus Vaccine Sales Quantity by Country (2024-2034) & (K Pcs)
Table 80. China Oral Rotavirus Vaccine Sales Quantity by Company (2018-2024) & (K Pcs)
Table 81. China Oral Rotavirus Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 82. China Oral Rotavirus Vaccine Sales Quantity by Type (2018-2024) & (K Pcs)
Table 83. China Oral Rotavirus Vaccine Sales Quantity by Type (2024-2034) & (K Pcs)
Table 84. China Oral Rotavirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 85. China Oral Rotavirus Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Oral Rotavirus Vaccine Sales Quantity by Application (2018-2024) & (K Pcs)
Table 87. China Oral Rotavirus Vaccine Sales Quantity by Application (2024-2034) & (K Pcs)
Table 88. China Oral Rotavirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 89. China Oral Rotavirus Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Oral Rotavirus Vaccine Sales Quantity by Company (2018-2024) & (K Pcs)
Table 91. APAC Oral Rotavirus Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 92. APAC Oral Rotavirus Vaccine Sales Quantity by Type (2018-2024) & (K Pcs)
Table 93. APAC Oral Rotavirus Vaccine Sales Quantity by Type (2024-2034) & (K Pcs)
Table 94. APAC Oral Rotavirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 95. APAC Oral Rotavirus Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Oral Rotavirus Vaccine Sales Quantity by Application (2018-2024) & (K Pcs)
Table 97. APAC Oral Rotavirus Vaccine Sales Quantity by Application (2024-2034) & (K Pcs)
Table 98. APAC Oral Rotavirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 99. APAC Oral Rotavirus Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Oral Rotavirus Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 101. APAC Oral Rotavirus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 102. APAC Oral Rotavirus Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Oral Rotavirus Vaccine Sales Quantity by Region (2018-2024) & (K Pcs)
Table 104. APAC Oral Rotavirus Vaccine Sales Quantity by Region (2024-2034) & (K Pcs)
Table 105. Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity by Company (2018-2024) & (K Pcs)
Table 106. Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity by Type (2018-2024) & (K Pcs)
Table 108. Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity by Type (2024-2034) & (K Pcs)
Table 109. Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity by Application (2018-2024) & (K Pcs)
Table 112. Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity by Application (2024-2034) & (K Pcs)
Table 113. Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 117. Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity by Country (2018-2024) & (K Pcs)
Table 119. Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity by Country (2024-2034) & (K Pcs)
Table 120. GSK Company Information
Table 121. GSK Description and Overview
Table 122. GSK Oral Rotavirus Vaccine Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 123. GSK Oral Rotavirus Vaccine Product and Services
Table 124. GSK Oral Rotavirus Vaccine SWOT Analysis
Table 125. GSK Recent Developments
Table 126. Sanofi-Pasteur Company Information
Table 127. Sanofi-Pasteur Description and Overview
Table 128. Sanofi-Pasteur Oral Rotavirus Vaccine Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 129. Sanofi-Pasteur Oral Rotavirus Vaccine Product and Services
Table 130. Sanofi-Pasteur Oral Rotavirus Vaccine SWOT Analysis
Table 131. Sanofi-Pasteur Recent Developments
Table 132. Merck Company Information
Table 133. Merck Description and Overview
Table 134. Merck Oral Rotavirus Vaccine Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 135. Merck Oral Rotavirus Vaccine Product and Services
Table 136. Merck Oral Rotavirus Vaccine SWOT Analysis
Table 137. Merck Recent Developments
Table 138. Biological E. Limited Company Information
Table 139. Biological E. Limited Description and Overview
Table 140. Biological E. Limited Oral Rotavirus Vaccine Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 141. Biological E. Limited Oral Rotavirus Vaccine Product and Services
Table 142. Biological E. Limited Oral Rotavirus Vaccine SWOT Analysis
Table 143. Biological E. Limited Recent Developments
Table 144. China National Biotec Group Company Information
Table 145. China National Biotec Group Description and Overview
Table 146. China National Biotec Group Oral Rotavirus Vaccine Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 147. China National Biotec Group Oral Rotavirus Vaccine Product and Services
Table 148. China National Biotec Group Oral Rotavirus Vaccine SWOT Analysis
Table 149. China National Biotec Group Recent Developments
Table 150. Sinovac Biotech Company Information
Table 151. Sinovac Biotech Description and Overview
Table 152. Sinovac Biotech Oral Rotavirus Vaccine Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Sinovac Biotech Oral Rotavirus Vaccine Product and Services
Table 154. Sinovac Biotech Oral Rotavirus Vaccine SWOT Analysis
Table 155. Sinovac Biotech Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Oral Rotavirus Vaccine Distributors List
Table 159. Oral Rotavirus Vaccine Customers List
Table 160. Oral Rotavirus Vaccine Market Trends
Table 161. Oral Rotavirus Vaccine Market Drivers
Table 162. Oral Rotavirus Vaccine Market Challenges
Table 163. Oral Rotavirus Vaccine Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Rotavirus Vaccine Product Picture
Figure 2. Global Oral Rotavirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Oral Rotavirus Vaccine Market Share by Type in 2022 & 2034
Figure 4. Rotarix Product Picture
Figure 5. RotaTeq Product Picture
Figure 6. Rotavac Product Picture
Figure 7. Rotavin-M1 Product Picture
Figure 8. Lanzhou lamb Product Picture
Figure 9. Global Oral Rotavirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 10. Global Oral Rotavirus Vaccine Market Share by Application in 2022 & 2034
Figure 11. Hospital
Figure 12. Vaccination Station
Figure 13. Other
Figure 14. Oral Rotavirus Vaccine Report Years Considered
Figure 15. Global Oral Rotavirus Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Oral Rotavirus Vaccine Revenue 2018-2034 (US$ Million)
Figure 17. Global Oral Rotavirus Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 18. Global Oral Rotavirus Vaccine Sales Quantity 2018-2034 (K Pcs)
Figure 19. Global Oral Rotavirus Vaccine Sales Quantity Market Share by Region (2018-2024)
Figure 20. Global Oral Rotavirus Vaccine Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Oral Rotavirus Vaccine Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 22. North America Oral Rotavirus Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Oral Rotavirus Vaccine Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. Europe Oral Rotavirus Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Oral Rotavirus Vaccine Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. China Oral Rotavirus Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Oral Rotavirus Vaccine Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. APAC Oral Rotavirus Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Oral Rotavirus Vaccine Sales Quantity in 2022
Figure 32. The Top 10 and Top 5 Players Market Share by Oral Rotavirus Vaccine Revenue in 2022
Figure 33. Oral Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Oral Rotavirus Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Oral Rotavirus Vaccine Revenue Market Share by Type (2018-2034)
Figure 36. Global Oral Rotavirus Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Oral Rotavirus Vaccine Revenue Market Share by Application (2018-2034)
Figure 38. North America Oral Rotavirus Vaccine Revenue Market Share by Company in 2022
Figure 39. North America Oral Rotavirus Vaccine Sales Quantity Market Share by Company in 2022
Figure 40. North America Oral Rotavirus Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Oral Rotavirus Vaccine Revenue Market Share by Type (2018-2034)
Figure 42. North America Oral Rotavirus Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Oral Rotavirus Vaccine Revenue Market Share by Application (2018-2034)
Figure 44. North America Oral Rotavirus Vaccine Revenue Share by Country (2018-2034)
Figure 45. North America Oral Rotavirus Vaccine Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Oral Rotavirus Vaccine Sales Quantity Market Share by Company in 2022
Figure 49. Europe Oral Rotavirus Vaccine Revenue Market Share by Company in 2022
Figure 50. Europe Oral Rotavirus Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Oral Rotavirus Vaccine Revenue Market Share by Type (2018-2034)
Figure 52. Europe Oral Rotavirus Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Oral Rotavirus Vaccine Revenue Market Share by Application (2018-2034)
Figure 54. Europe Oral Rotavirus Vaccine Revenue Share by Country (2018-2034)
Figure 55. Europe Oral Rotavirus Vaccine Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 57. France Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 61. China Oral Rotavirus Vaccine Sales Quantity Market Share by Company in 2022
Figure 62. China Oral Rotavirus Vaccine Revenue Market Share by Company in 2022
Figure 63. China Oral Rotavirus Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Oral Rotavirus Vaccine Revenue Market Share by Type (2018-2034)
Figure 65. China Oral Rotavirus Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Oral Rotavirus Vaccine Revenue Market Share by Application (2018-2034)
Figure 67. APAC Oral Rotavirus Vaccine Sales Quantity Market Share by Company in 2022
Figure 68. APAC Oral Rotavirus Vaccine Revenue Market Share by Company in 2022
Figure 69. APAC Oral Rotavirus Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Oral Rotavirus Vaccine Revenue Market Share by Type (2018-2034)
Figure 71. APAC Oral Rotavirus Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Oral Rotavirus Vaccine Revenue Market Share by Application (2018-2034)
Figure 73. APAC Oral Rotavirus Vaccine Revenue Share by Region (2018-2034)
Figure 74. APAC Oral Rotavirus Vaccine Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 79. India Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue Market Share by Company in 2022
Figure 82. Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Oral Rotavirus Vaccine Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Oral Rotavirus Vaccine Revenue Share by Country (2018-2034)
Figure 88. Brazil Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Oral Rotavirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 93. Oral Rotavirus Vaccine Value Chain
Figure 94. Oral Rotavirus Vaccine Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries